News

Eurostars project NO-PNP launched: a new approach to neuropathic pain

Together with Akasi Pharma and IVRS AB, NovoArc is developing a long-acting, non-opioid treatment for neuropathic pain. NovoArc is contributing its liposomal TEL platform to the project.

Read more

Gold for NovoArc at the Born Global Champion Awards

The award honors companies that successfully enter international markets at an early stage, demonstrate strong export performance, and show the potential to create lasting global impact.

Read more

Recognized Among Austria’s Top 100 Startups

We’re incredibly proud to share that our company has been selected for TREND Magazine’s 2025 ranking of Austria’s Top 100 Startups.

Read more

More Than Teammates

Sometimes the most important work happens away from our desks.

Read more

A Visit from District Mayor Zankl

We were delighted to welcome District Mayor Zankl to our facility.

Read more

Nanoparticle Formulation Symposium 2025

We were pleased to contribute to the Nanoparticle Formulation Symposium in London as an invited speaker, sharing insights into current and emerging approaches in nanoparticle development.

Read more

A Great Conversation on the Austrian Patent Office Podcast

We would like to thank the team at the Austrian Patent Office, and in particular Julia Zach, for the kind invitation to participate in the podcast and for the engaging and insightful conversation.

Read more

mRNA Health Conference 2025

NovoArc GmbH is joining forces to advance the next generation of lipid innovation.

Read more

BIO-Europe 2025

We were pleased to attend BIO-Europe, where we connected with partners and stakeholders from across the global biotechnology landscape.

Read more

Internship at NovoArc

We recently had the pleasure of welcoming Prof. Bernhard Klausgraber from IMC Krems University of Applied Sciences to NovoArc GmbH. Prof. Klausgraber is the academic supervisor of our intern Ema Doneva, who is currently completing her Practical Training Semester with us.

Read more